Literature DB >> 16903079

Relationships between the larval growth inhibition of Caenorhabditis elegans by apigenin derivatives and their structures.

Young-Ah Yoon1, Hojung Kim, Yoongho Lim, Yhong-Hee Shim.   

Abstract

Due to consumer reluctance to take synthetic drugs for nematode infections and the appearance of resistance to anthelminthic drugs, new drugs from natural products must be developed. Caenorhabditis elegans is one of the freely living nematodes and serves as a good model system for screening anthelminthic drugs. In this study, thirteen flavonoid derivatives were tested for anthelminthic activity and the relationships between their activities and structures were investigated. The structural information combined with the data for the larval growth inhibition of C. elegans provided meaningful structural insights in the search for new anthelminthic drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16903079     DOI: 10.1007/bf02969269

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Transcriptome analysis reveals molecular anthelmintic effects of procyanidins in C. elegans.

Authors:  Verena Spiegler; Andreas Hensel; Jochen Seggewiß; Milena Lubisch; Eva Liebau
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

Review 2.  An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia.

Authors:  Sutthaya Poolperm; Wannee Jiraungkoorskul
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

3.  Some effects of a chrysin bromide-derivative on GABA-A receptors and on Caenorhabditis elegans.

Authors:  José Téllez-Arreola; Alejandro Valdez-Calderón; Simplicio González-Montiel; Ataúlfo Martinez-Torres; Adan Hernandez
Journal:  MicroPubl Biol       Date:  2019-01-28

4.  Metabolite induction of Caenorhabditis elegans dauer larvae arises via transport in the pharynx.

Authors:  Thomas J Baiga; Haibing Guo; Yalan Xing; George A O'Doherty; Andrew Dillin; Michael B Austin; Joseph P Noel; James J La Clair
Journal:  ACS Chem Biol       Date:  2008-04-01       Impact factor: 5.100

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.